FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2626084904> ?p ?o ?g. }

• W2626084904 endingPage "4007" @default.
• W2626084904 startingPage "4007" @default.
• W2626084904 abstract "To examine the influence on apoptotic mechanisms following inhibition of polo-like kinases as therapeutically approach for cholangiocellular cancer treatment.As most cholangiocarcinomas are chemotherapy-resistant due to mechanisms preventing tumor cell death, we investigated the effect of Cisplatin on cholangiocellular carcinoma (CCA) cell lines KMCH-1 and Mz-Ch-1. Polo-like kinases (PLK) are important regulators of the cell cycle and their inhibition is discussed as a potential therapy while PLK inhibition can regulate apoptotic mediators. Here, cells were treated with PLK inhibitor BI6727 (Volasertib), Cisplatin, and in combination of both compounds. Cell viability was assessed by MTT; apoptosis was measured by DAPI staining and caspase-3/-7 assay. Western blot and qRT-PCR were used to measure expression levels of apoptosis-related molecules Bax and Bcl-2.The cell viability in the CCA cell lines KMCH-1 and Mz-Ch-1 was reduced in all treatment conditions compared to vehicle-treated cells. Co-treatment with BI6727 and cisplatin could even enhance the cytotoxic effect of cisplatin single treatment. Thus, co-treatment of cisplatin with BI6727 could slightly enhance the cytotoxic effect of the cisplatin in both cell lines whereas there was evidence of increased apoptosis induction solely in Mz-Ch-1 as compared to KMCH-1. Moreover, PLK inhibition decreases protein levels of Bcl-2; an effect that can be reversed by the proteasomal degradation inhibitor MG-132. In contrast, protein levels of Bax were not found to be altered by PLK inhibition. These findings indicate that cytotoxic effects of Cisplatin in Mz-Ch-1 cells can be enhanced by cotreatment with BI6727.In conclusion, BI6727 treatment can sensitize CCA cells to cisplatin-induced apoptosis with proteasomal Bcl-2 degradation as an additional pro-apoptotic effect." @default.
• W2626084904 created "2017-06-23" @default.
• W2626084904 creator A5000630268 @default.
• W2626084904 creator A5001703227 @default.
• W2626084904 creator A5002473571 @default.
• W2626084904 creator A5018899274 @default.
• W2626084904 creator A5030335749 @default.
• W2626084904 creator A5042438955 @default.
• W2626084904 creator A5045395819 @default.
• W2626084904 creator A5061830141 @default.
• W2626084904 creator A5071899214 @default.
• W2626084904 date "2017-01-01" @default.
• W2626084904 modified "2023-10-18" @default.
• W2626084904 title "Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells" @default.
• W2626084904 cites W1484817497 @default.
• W2626084904 cites W1525608409 @default.
• W2626084904 cites W1584172336 @default.
• W2626084904 cites W1586027123 @default.
• W2626084904 cites W1978480779 @default.
• W2626084904 cites W1980050556 @default.
• W2626084904 cites W1987506447 @default.
• W2626084904 cites W2003408967 @default.
• W2626084904 cites W2003411025 @default.
• W2626084904 cites W2003997716 @default.
• W2626084904 cites W2007242949 @default.
• W2626084904 cites W2009443523 @default.
• W2626084904 cites W2017807973 @default.
• W2626084904 cites W2018087357 @default.
• W2626084904 cites W2020411912 @default.
• W2626084904 cites W2028700227 @default.
• W2626084904 cites W2029108033 @default.
• W2626084904 cites W2032637906 @default.
• W2626084904 cites W2035515971 @default.
• W2626084904 cites W2041812469 @default.
• W2626084904 cites W2053272914 @default.
• W2626084904 cites W2060951562 @default.
• W2626084904 cites W2062374027 @default.
• W2626084904 cites W2073047578 @default.
• W2626084904 cites W2076183717 @default.
• W2626084904 cites W2079463756 @default.
• W2626084904 cites W2105754149 @default.
• W2626084904 cites W2112327309 @default.
• W2626084904 cites W2114135705 @default.
• W2626084904 cites W2117443078 @default.
• W2626084904 cites W2124221273 @default.
• W2626084904 cites W2128016549 @default.
• W2626084904 cites W2139320422 @default.
• W2626084904 cites W2141037581 @default.
• W2626084904 cites W2142990170 @default.
• W2626084904 cites W2147318282 @default.
• W2626084904 cites W2151650153 @default.
• W2626084904 cites W2167831982 @default.
• W2626084904 cites W2223819126 @default.
• W2626084904 cites W4211025847 @default.
• W2626084904 cites W4246018467 @default.
• W2626084904 cites W4249393610 @default.
• W2626084904 doi "https://doi.org/10.3748/wjg.v23.i22.4007" @default.
• W2626084904 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5473120" @default.
• W2626084904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28652654" @default.
• W2626084904 hasPublicationYear "2017" @default.
• W2626084904 type Work @default.
• W2626084904 sameAs 2626084904 @default.
• W2626084904 citedByCount "7" @default.
• W2626084904 countsByYear W26260849042018 @default.
• W2626084904 countsByYear W26260849042020 @default.
• W2626084904 countsByYear W26260849042022 @default.
• W2626084904 crossrefType "journal-article" @default.
• W2626084904 hasAuthorship W2626084904A5000630268 @default.
• W2626084904 hasAuthorship W2626084904A5001703227 @default.
• W2626084904 hasAuthorship W2626084904A5002473571 @default.
• W2626084904 hasAuthorship W2626084904A5018899274 @default.
• W2626084904 hasAuthorship W2626084904A5030335749 @default.
• W2626084904 hasAuthorship W2626084904A5042438955 @default.
• W2626084904 hasAuthorship W2626084904A5045395819 @default.
• W2626084904 hasAuthorship W2626084904A5061830141 @default.
• W2626084904 hasAuthorship W2626084904A5071899214 @default.
• W2626084904 hasBestOaLocation W26260849041 @default.
• W2626084904 hasConcept C153911025 @default.
• W2626084904 hasConcept C154317977 @default.
• W2626084904 hasConcept C184235292 @default.
• W2626084904 hasConcept C185592680 @default.
• W2626084904 hasConcept C190283241 @default.
• W2626084904 hasConcept C202751555 @default.
• W2626084904 hasConcept C2776694085 @default.
• W2626084904 hasConcept C2777527632 @default.
• W2626084904 hasConcept C2778239845 @default.
• W2626084904 hasConcept C2780783641 @default.
• W2626084904 hasConcept C29537977 @default.
• W2626084904 hasConcept C502942594 @default.
• W2626084904 hasConcept C53227056 @default.
• W2626084904 hasConcept C54355233 @default.
• W2626084904 hasConcept C55493867 @default.
• W2626084904 hasConcept C81885089 @default.
• W2626084904 hasConcept C84815855 @default.
• W2626084904 hasConcept C86803240 @default.
• W2626084904 hasConcept C95444343 @default.
• W2626084904 hasConceptScore W2626084904C153911025 @default.
• W2626084904 hasConceptScore W2626084904C154317977 @default.

• next